DANIELLE OTIS: Open Payments
NPI 1457708109 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$900 in 33 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $864 · 2025 $900
Food & beverage: $800Education: $100
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 4 | $118 |
| Novartis Pharmaceuticals Corporation | 4 | $105 |
| SEAGEN INC. | 1 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $79 |
| BeiGene USA, Inc. | 2 | $53 |
| PFIZER INC. | 2 | $43 |
| ABBVIE INC. | 1 | $33 |
| Sirtex Medical Inc | 1 | $33 |
| Janssen Biotech, Inc. | 1 | $30 |
| Incyte Corporation | 1 | $28 |
Products named: KISQALI, BRUKINSA, KEYTRUDA, FRUZAQLA, LYNPARZA, EMRELIS, SIR-Spheres Microspheres, RYBREVANT.
Industry payments across MI — which companies pay providers there.
